| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/26/2011 | US20110123992 Probe, probe set, probe carrier, and testing method |
| 05/26/2011 | US20110123991 Isothermal nucleic acid amplification |
| 05/26/2011 | US20110123990 Methods To Predict Clinical Outcome Of Cancer |
| 05/26/2011 | US20110123989 Method for the detection of schizophrenia related gene transcripts in blood |
| 05/26/2011 | US20110123988 Antisense compounds and methods for diagnostic imaging |
| 05/26/2011 | US20110123987 Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/26/2011 | US20110123986 Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/26/2011 | US20110123985 Column enrichment of pcr beads comprising tethered amplicons |
| 05/26/2011 | US20110123984 Fam26c polymorphisms and use thereof for the diagnostic and treatment of late onset alzheimer's disease |
| 05/26/2011 | US20110123983 Methods of Using Genetic Markers and Related Epistatic Interactions |
| 05/26/2011 | US20110123982 Nucleic acid based fluorescent sensor for copper detection |
| 05/26/2011 | US20110123981 Fto gene polymorphisms associated to obesity and/or type ii diabetes |
| 05/26/2011 | US20110123980 Sequence-specific detection of nucleotide sequences |
| 05/26/2011 | US20110123979 Detection of microorganisms |
| 05/26/2011 | US20110123978 Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs) |
| 05/26/2011 | US20110123977 Method for taking a plurality of samples |
| 05/26/2011 | US20110123976 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using NMR |
| 05/26/2011 | US20110123602 Molecular lymphatic mapping of sentinel lymph nodes |
| 05/26/2011 | US20110123566 Endogenous adjuvant molecules and uses thereof |
| 05/26/2011 | US20110123557 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1 |
| 05/26/2011 | US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 05/26/2011 | US20110123538 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease |
| 05/26/2011 | US20110123537 Binding epitopes for g250 antibody |
| 05/26/2011 | US20110123530 Compositions and methods for treating and diagnosing asthma |
| 05/26/2011 | US20110123515 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 05/26/2011 | US20110123488 Method of Treatment for Cancers Associated with Elevated HER2 Levels |
| 05/26/2011 | US20110123484 Methods and compositions for treating fus1 related disorders |
| 05/26/2011 | US20110123482 Methods of Treating Neurological Autoimmune Disorders with Cyclophosphamide |
| 05/26/2011 | US20110123455 Rational design of regenerative medicine products |
| 05/26/2011 | US20110123454 Method for modulating appetite |
| 05/26/2011 | US20110123449 Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 05/26/2011 | US20110122498 Annular solid immersion lenses and methods of making them |
| 05/26/2011 | DE102009054057A1 Screening-Verfahren für Wirkstoffe für die Prophylaxe und Therapie neurodegenerativer Erkrankungen Screening procedures for drugs for the prophylaxis and treatment of neurodegenerative diseases |
| 05/26/2011 | DE102009050287A1 SERS-Substrat SERS substrate |
| 05/26/2011 | DE102006032610B4 Verfahren zur parallelen Isolierung viraler Nukleinsäuren A method for parallel isolation of viral nucleic acids |
| 05/26/2011 | CA2818514A1 Bioreactors, systems, and methods for producing and/or analyzing organs |
| 05/26/2011 | CA2781598A1 Herbicide tolerant soybean plants and methods for identifying same |
| 05/26/2011 | CA2781557A1 Elite event ee-gm3 and methods and kits for identifying such event in biological samples |
| 05/26/2011 | CA2781547A1 Materials and methods useful for affecting tumor cell growth, migration and invasion |
| 05/26/2011 | CA2781469A1 Devices to extend single stranded target molecules |
| 05/26/2011 | CA2781194A1 Reducing inflammation using cell therapy |
| 05/26/2011 | CA2781126A1 Variegation in plants |
| 05/26/2011 | CA2781074A1 Genetic markers for weight management and methods of use thereof |
| 05/26/2011 | CA2780807A1 Methods, devices, kits and compositions for detecting roundworm |
| 05/26/2011 | CA2780448A1 Transgenic maize event mon 87427 and the relative development scale |
| 05/26/2011 | CA2779860A1 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/26/2011 | CA2776751A1 Methods to predict clinical outcome of cancer |
| 05/26/2011 | CA2775970A1 Methods of inducing tissue regeneration |
| 05/25/2011 | EP2325779A2 Processing images of biological growth plates |
| 05/25/2011 | EP2325652A2 Postprandial hyperglycemia marker, method of measuring the same, and usage thereof |
| 05/25/2011 | EP2325648A1 Cancer detection method |
| 05/25/2011 | EP2325647A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XX |
| 05/25/2011 | EP2325646A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XVII |
| 05/25/2011 | EP2325645A2 Sequences for detection and identification of methicillin-resistant Staphylococcus Aureus (MRSA) of MREJ type xiii |
| 05/25/2011 | EP2325644A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XII |
| 05/25/2011 | EP2325643A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XV |
| 05/25/2011 | EP2325642A1 Use of multimodality nanostructures to detect target substances |
| 05/25/2011 | EP2325641A1 Biological indicator |
| 05/25/2011 | EP2325631A1 Antibody conjugated to peptide via a UV cleavable linker |
| 05/25/2011 | EP2325340A1 MicroRNAs and uses thereof |
| 05/25/2011 | EP2325339A2 Methods and compositions for generation of germline human antibody genes |
| 05/25/2011 | EP2325338A2 Markers for detection of gastric cancer |
| 05/25/2011 | EP2325337A1 RNA aptamers and methods for identifying the same |
| 05/25/2011 | EP2325336A1 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 05/25/2011 | EP2325335A2 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| 05/25/2011 | EP2325334A1 mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancer |
| 05/25/2011 | EP2325333A1 MicrorRNAs and uses thereof |
| 05/25/2011 | EP2325332A1 Use of crispr associated genes (CAS) |
| 05/25/2011 | EP2325331A1 MicroRNAs and Uses Thereof |
| 05/25/2011 | EP2325330A1 METHOD FOR SIMULTANEOUS DETECTION OF VIROIDS PSTVd AND TCDVd |
| 05/25/2011 | EP2325329A1 Improved luciferase-based assays |
| 05/25/2011 | EP2325328A1 Improved luciferase-based assays |
| 05/25/2011 | EP2325327A1 Method for evaluating specific incorporation of d-glucose into cells |
| 05/25/2011 | EP2325326A1 Technique for estimating cell conditions and image processor for cell observation |
| 05/25/2011 | EP2325325A1 Methods for the reduction of stutter in microsatellite amplification |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325313A2 pRNA chimera |
| 05/25/2011 | EP2325310A1 Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin |
| 05/25/2011 | EP2325309A1 Method for detection of paecilomyces variotii |
| 05/25/2011 | EP2325308A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 05/25/2011 | EP2325306A1 Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides |
| 05/25/2011 | EP2325305A1 Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides |
| 05/25/2011 | EP2325303A2 Thermostable reverse transcriptases and uses thereof |
| 05/25/2011 | EP2325302A1 Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) |
| 05/25/2011 | EP2325301A1 Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) |
| 05/25/2011 | EP2325299A2 Methods for generating high titer helper-free preparations of recombinant AAV vectors |
| 05/25/2011 | EP2325294A2 Visual-servoing optical microscopy |
| 05/25/2011 | EP2325203A2 Cadherin materials and methods |
| 05/25/2011 | EP2325202A1 Uses of interferons with altered spatial structure |
| 05/25/2011 | EP2325198A1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 05/25/2011 | EP2325196A1 Replikin peptides and uses thereof |
| 05/25/2011 | EP2324856A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 05/25/2011 | EP2324839A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324767A1 Process for producing an electrochemical biosensor |
| 05/25/2011 | EP2324130A1 Nucleic acid amplification |
| 05/25/2011 | EP2324129A1 Methods and compositions for determining a graft tolerant phenotype in a subject |
| 05/25/2011 | EP2324128A1 Temperature controlled nucleic-acid detection method suitable for practice in a closed-system |
| 05/25/2011 | EP2324127A2 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity |
| 05/25/2011 | EP2324126A2 Method of identifying disease risk factors |